• Explore /
  • Poster
  • / The role of germline polymorphisms in genes involved in the antioxidant system to predict the efficacy of cetuximab for patients with metastatic colorectal cancer (mCRC) enrolled in FIRE-3 trial.

The role of germline polymorphisms in genes involved in the antioxidant system to predict the efficacy of cetuximab for patients with metastatic colorectal cancer (mCRC) enrolled in FIRE-3 trial.

Abstract Poster

Authors

null

Hiroyuki Arai

Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA

Hiroyuki Arai , Joshua Millstein , Sebastian Stintzing , Jingyuan Wang , Francesca Battaglin , Natsuko Kawanishi , Priya Jayachandran , Shivani Soni , Zhang Wu , Volker Heinemann , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Translational Research

DOI

10.1200/JCO.2022.40.4_suppl.143

Abstract #

143

Poster Bd #

M5

Abstract Disclosures

Similar Posters

First Author: Hiroyuki Arai

First Author: Hiroyuki Arai

First Author: Francesca Battaglin

First Author: Jingyuan Wang